Document text
Principal Investigator: Avindra Nath
Organization: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Fiscal Year: 2024
Award: $1,451,554
Funding agency: National Institute of Neurological Disorders and Stroke
Objective: The primary objective is to explore the clinical and biological phenotypes of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) and post-acute sequelae of COVID-19 (PASC). The secondary objective is to explore the pathophysiology of fatigue and post-exertional malaise (PEM).
Study population: Up to 1890 persons will be enrolled as part of the protocols.
For ME/CFS, up to 150 persons aged 18-60 will be part of 3 study groups: 50 ME/CFS patients whose fatigue began after an infection, 50 non-fatigued participants with a documented history of Lyme disease exposure and treatment, and 50 healthy volunteers. The study has a target of completing all study procedures on 20 enrolled participants in each group. Up to an additional 176 persons reporting a community diagnosis of ME/CFS will be enrolled into focus groups to discuss the experience of post-exertional malaise. Up to an additional 10 healthy volunteers and 10 ME/CFS patients may be enrolled to refine the protocols' electrophysiological and neuroimaging techniques.
For PASC, up to 1540 persons 18 years of age or older will participate in a Survey study, in which telephone interviews and internet-based questionnaires will be collected for both descriptive research and participant screening purposes. From this group, up to 240 PASC patients and SARS-CoV-2 recovered volunteers will be enrolled in an inpatient evaluation visit. From this group, up to 110 PASC patients and SARS-CoV-2 recovered volunteers will be enrolled in an inpatient exercise stress visit.
Design: This is a single-center, exploratory, cross-sectional study of PI-ME/CFS and PASC. Participants will have an initial visit, which will encompass 5 day long inpatient admission at the NIH Clinical Center. Case status for ME/CFS and PASC participants will be determined after the visit by a case adjudication process utilizing an expert physician committee and published guidelines. Adjudicated participants meeting inclusion criteria may be invited back to participate in an exercise stress visit, which will encompass a 5 day long inpatient admission. Detailed subjective and objective measurements and biological specimens will be serially collected before and up to 96 hours after a peak exercise test capable of inducing post-exertional malaise during this visit. All procedures will be completed on all three study groups to allow for optimal inter-group comparisons.
Outcome Measures: The primary purpose of this protocol is to perform exploratory analysis of collected samples for the generation of new hypotheses regarding ME/CFS and PASC. The types of analyses to be performed will be wide ranging. Planned areas of focus include:
1. Characterization of the immune system and inflammatory signaling in collected samples at baseline and following maximal exercise exertion.
2. Characterization of the pattern of microbiome in collected samples at baseline and following maximal exercise exertion.
3. Characterization of bioenergetics, autonomic, and metabolic function in collected samples at baseline and following maximal exercise exertion.
4. Characterization of physical and cognitive fatigue using functional magnetic resonance imaging and transcranial magnetic stimulation at baseline and following maximal exercise exertion.
5. Characterization of neurocognition at baseline and following maximal exercise exertion.
6. Characterization of brain function and connectivity at baseline and following maximal exercise exertion.
7. Characterization of autonomic function at baseline and following maximal exercise exertion.
8. Characterization of gene expression profiles in collected samples at baseline and following maximal exercise exertion.
Results Summary (To Date):
PI-ME/CFS: Among the many physical and cognitive complaints, one defining feature of PI-ME/CFS was an alteration of effort preference, rather than physical or central fatigue, due to dysfunction of integrative brain regions potentially associated with central catechol pathway dysregulation, with consequences on autonomic functioning and physical conditioning. Immune profiling suggested chronic antigenic stimulation with increase in naïve and decrease in switched memory B-cells. Alterations in gene expression profiles of peripheral blood mononuclear cells and metabolic pathways were consistent with cellular phenotypic studies and demonstrated differences according to sex. (Walitt, Nature Communications, 2024)
PASC: Participants with PASC were mostly female (83%), with a mean age of 45 ± 11 years. The median time of evaluation was 9 months after COVID-19 (range 3-12 months), and most (11/12, 92%) had a history of only a mild infection. The most common neuro-PASC symptoms were cognitive difficulties and fatigue, and there was evidence for mild cognitive impairment in half of the patients. Analysis of Cerebral Spinal Fluid (CSF) revealed alterations in immune function and neurocirculation. CSF immune dysregulation and neurocirculatory abnormalities after SARS-CoV-2 infection in the setting of disabling neuro-PASC call for further evaluation to confirm these changes and explore immunomodulatory treatments in the context of clinical trials. (Mina, Neurol Neuroimmunol Neuroinflamm. 2023)
Terms: <1,2-benzenediol><1,2-dihydroxybenzene><18 year old><18 years of age><2-hydroxyphenol><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Admission><Admission activity><Age><Area><Back><Bioenergetics><Biological><Brain><Brain Nervous System><Brain region><COVID infected patient><COVID patient><COVID positive patient><COVID-19 infected patient><COVID-19 neural sequela><COVID-19 patient><COVID-19 positive patient><COVID-19 virus><COVID19 patient><COVID19 positive patient><COVID19 virus><Catechols><Cell Communication and Signaling><Cell Signaling><Cellular Immune Function><Cerebrospinal Fluid><Chronic><Chronic Fatigue Disorder><Chronic Fatigue Syndrome><Chronic Fatigue and Immune Dysfunction Syndrome><Chronic Infectious Mononucleosis-Like Syndrome><Clinical><Clinical Trials><CoV-2><CoV2><Cognitive><Communication><Communities><Cross Sectional Analysis><Cross-Sectional Analyses><Cross-Sectional Studies><Cross-Sectional Survey><Diagnosis><Disabling><Disease Frequency Surveys><Dorsum><Dysfunction><Electrophysiology><Electrophysiology (science)><Encephalon><Enrollment><Evaluation><Exercise><Exercise Test><Exertion><Expression Signature><Fatigue><Female><Focus Groups><Functional MRI><Functional Magnetic Resonance Imaging><Functional disorder><Gene Expression Profile><Generations><Guidelines><History><Hour><Immune><Immune Modulation Therapy><Immune system><Immunes><Infection><Inflammatory><Inpatients><Internet><Intracellular Communication and Signaling><Lack of Energy><Lyme Borreliosis><Lyme Disease><ME/CFS><Malaise><Measurement><Measures><Memory B Cell><Memory B-Lymphocyte><Metabolic><Metabolic Pathway><Muscle><Muscle Tissue><Myalgic Encephalomyelitis><NIH><National Institutes of Health><Nature><Neurocognition><Neurophysiology / Electrophysiology><Outcome Measure><PASC><PBMC><Participant><Pathway interactions><Patients><Pattern><Peripheral Blood Mononuclear Cell><Persons><Phenotype><Physicians><Physiopathology><Post Acute Sequelae of COVID19><Post Acute Sequelae of SARS-CoV-2><Post Acute Sequelae of SARS-CoV2><Post Acute Sequelae of severe acute respiratory syndrome coronavirus 2><Post-Acute Sequelae of SARS-CoV-2 Infection><Postviral Fatigue Syndrome><Procedures><Process><Protocol><Protocols documentation><Publishing><Pyrocatechols><Questionnaires><Recording of previous events><Reporting><Research><Research Specimen><Royal Free Disease><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 infected patient><SARS-CoV-2 neurological sequelae><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Signal Transduction><Signal Transduction Systems><Signaling><Specimen><Stress><Survey Instrument><Surveys><Symptoms><Syndrome><Techniques><Telephone Interviews><Time><Transcranial magnetic stimulation><United States National Institutes of Health><Viral><Visit><WWW><Wuhan coronavirus><adjudication><adjudicative process and procedure><adverse sequelae of COVID><adverse sequelae of COVID-19><adverse sequelae of coronavirus disease><adverse sequelae of coronavirus disease 2019><after COVID-19 infection><after SARS-CoV-2 infection><after SARS-CoV2 infection><after infection by SARS-CoV-2><after severe acute respiratory distress syndrome CoV-2 infection><age 18 years><aged><ages><biologic><biological signal transduction><cerebral spinal fluid><chronic COVID-19 sequelae><clinical center><coronavirus disease 2019 infected patient><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 virus><coronavirus disease infected patient><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19 patient><coronavirus disease-19 virus><coronavirus patient><design><designing><eighteen year old><eighteen years of age><electrophysiological><enroll><experience><fMRI><following COVID-19 infection><following SARS-CoV-2 infection><following SARS-CoV2 infection><following infection by SARS-CoV-2><following severe acute respiratory distress syndrome CoV-2 infection><gene expression pattern><gene expression signature><hCoV19><healthy volunteer><histories><immune function><immune modulating therapies><immune modulatory therapies><immune-modulation treatment><immunomodulation therapy><immunomodulation treatment><immunomodulator therapies><immunomodulator treatment><immunomodulator-based therapies><immunomodulatory therapies><immunomodulatory therapy><immunomodulatory treatment><inclusion criteria><long haul sequelae of COVID-19><long haul sequelae of coronavirus disease 2019><long-term sequelae of COVID-19><long-term sequelae of SARS-CoV-2><long-term sequelae of coronavirus disease 2019><long-term sequelae of severe acute respiratory syndrome coronavirus 2><measurable outcome><meeting><meetings><microbiome><mild cognitive disorder><mild cognitive impairment><muscular><nCoV2><neural imaging><neural sequela in COVID-19><neuro post-acute sequelae of SARS-CoV-2><neuro-imaging><neuroPASC><neuroimaging><neurologic post acute sequelae of SARS-CoV-2><neurologic sequelae of COVID-19><neurological imaging><neurological post-acute sequelae of SARS-CoV-2><neurological sequelae associated with SARS-CoV-2><neurological sequelae caused by SARS-CoV-2><o-Dihydroxybenzenes><ortho-Dihydroxybenzenes><outcome measurement><participant enrollment><pathophysiology><pathway><patient enrollment><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><physical conditioning><physical health><post COVID-19 sequelae><post SARS-CoV-2 infection><post acute sequelae following COVID-19><post-acute CNS symptoms of SARS-CoV-2 infection><post-acute sequelae following SARS-CoV-2 infection><post-acute sequelae of COVID-19><post-acute sequelae of acute COVID infection><post-acute sequelae of coronavirus disease 2019><preference><previous COVID-19 infection><previous SARS-CoV-2 infection><previous SARS-CoV2 infection><previous severe acute respiratory distress syndrome CoV-2 infection><prior COVID-19 infection><prior SARS-CoV-2 infection><prior SARS-CoV2 infection><prior severe acute respiratory distress syndrome CoV-2 infection><screening><screenings><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><sex><spinal fluid><study population><transcriptional profile><transcriptional signature><volunteer><web><world wide web>